Skip to main content
Beijing Airdoc Technology Co., Ltd. logo

Beijing Airdoc Technology Co., Ltd. — Investor Relations & Filings

Ticker · 2251 HKEX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 271 across all filing types
Latest filing 2025-03-17 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 2251

About Beijing Airdoc Technology Co., Ltd.

http://www.airdoc.com

Beijing Airdoc Technology Co., Ltd. is a pioneer and leader in AI-based retinal imaging, specializing in AI-empowered systems for early detection, diagnosis, and health risk assessment. The company's core technology utilizes artificial intelligence to analyze single retinal images, providing evaluation for up to 55 risks related to chronic diseases. Airdoc develops and commercializes diagnostic imaging tools, such as Airdoc-Aifundus, primarily targeting medical institutions and healthcare providers. Additionally, Airdoc addresses the consumer market with products like the PBM Visual Function Improvement System, which employs photobiomodulation technology for the non-invasive management and control of myopia progression in children and adolescents. This dual focus positions Airdoc as a comprehensive provider of multi-faceted AI solutions across medical diagnostics and preventative eye health.

Recent filings

Filing Released Lang Actions
DATE OF BOARD MEETING
Report Publication Announcement Classification · 1% confidence The document is a short corporate announcement filed on the Hong Kong Exchange stating the date of the Board meeting that will consider and approve the annual results and publication of the Company’s 2024 results. It does not present the results themselves, nor detail financial data or dividends; it simply notifies investors of the timing for the Board’s approval and subsequent release of the annual report. This matches the definition of a Report Publication Announcement (RPA) rather than an actual Annual Report (10-K) or Earnings Release (ER), and it is not a Board/Management change notice (MANG).
2025-03-17 English
PROFIT WARNING
Regulatory Filings Classification · 1% confidence The document is a profit warning issued under HKEX Listing Rule 13.09(2) and Part XIVA of the Securities and Futures Ordinance. It provides preliminary unaudited loss estimates for the full year ending December 31, 2024, along with regulatory background, but does not present actual audited results nor is it the formal annual or interim report. It is not simply an announcement that a report is attached (so not RPA) and does not fit any other specific category (e.g., earnings release, dividend notice, capital change). Therefore, it is best classified as a general regulatory announcement (fallback) under Regulatory Filings (RNS).
2025-03-10 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 28 February 2025
Regulatory Filings Classification · 1% confidence The document is an FF301 Monthly Return for Equity Issuers under Hong Kong Listing Rules, detailing movements in registered share capital, issued shares and treasury shares for the month. It is a routine regulatory submission to the Hong Kong Exchange rather than an earnings release, management discussion, share issue, dividend notice or other specific event. It does not announce any new share issuance or repurchase (all changes are zero), but fulfills a Listing Rule requirement. No specific section in our taxonomy covers monthly listing returns, so it defaults to a general regulatory filing. Therefore, it should be classified as RNS.
2025-03-05 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 January 2025
Regulatory Filings Classification · 1% confidence The document is a mandatory monthly return (Form FF301) submitted to the Hong Kong Stock Exchange, detailing movements in authorised/registered share capital, issued shares and treasury shares, share repurchases, confirmations under Main Board Rules, etc. It is not an annual or interim financial report, earnings release, management discussion, AGM material, nor a singular announcement of a share issue, dividend, merger, or delisting. It is a routine regulatory filing summarizing capital movements under Chapter 19B. It does not fit any specialized category (e.g., SHA or POS) since it aggregates both share capital and treasury share data on a periodic basis. Therefore it is best classified as a general regulatory filing (RNS).
2025-02-05 English
CHANGE OF JOINT COMPANY SECRETARY AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES
Board/Management Information Classification · 1% confidence The document is an official announcement on the Hong Kong Stock Exchange regarding a resignation and appointment of a joint company secretary, which is a change in senior management/board-level support roles. It does not present financial results, proxy materials, or regulatory filings beyond management changes. Therefore, it falls under Board/Management Information.
2025-01-20 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Hong Kong Stock Exchange Next Day Disclosure Return (Form FF305) detailing changes in issued shares and a repurchase of treasury shares (on‐market share buyback). It is not an AGM presentation or annual report but a mandatory disclosure of the company’s own share transactions. This matches the “Transaction in Own Shares” category (POS).
2025-01-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.